Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Change in Acquisitions & Divestments (2022 - 2026)

Atea Pharmaceuticals' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $104.3 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 49.92% to $104.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $366.8 million through Mar 2026, down 26.87% year-over-year, with the annual reading at $470.7 million for FY2025, 9.0% down from the prior year.
  • Change in Acquisitions & Divestments came in at $104.3 million for Q1 2026, up from $90.4 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $224.0 million in Q1 2024 to a low of $55.1 million in Q4 2024.
  • The 5-year median for Change in Acquisitions & Divestments is $111.1 million (2024), against an average of $127.6 million.
  • Year-over-year, Change in Acquisitions & Divestments surged 64.02% in 2025 and then crashed 49.92% in 2026.
  • Atea Pharmaceuticals' Change in Acquisitions & Divestments stood at $91.9 million in 2022, then dropped by 18.38% to $75.0 million in 2023, then decreased by 26.53% to $55.1 million in 2024, then soared by 64.02% to $90.4 million in 2025, then rose by 15.38% to $104.3 million in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Change in Acquisitions & Divestments are $104.3 million (Q1 2026), $90.4 million (Q4 2025), and $56.1 million (Q3 2025).